The stock of Nutraceutical Int’l Corp. (NASDAQ:NUTR) hit a new 52-week high and has $35.10 target or 8.00% above today’s $32.50 share price. The 7 months bullish chart indicates low risk for the $304.75M company. The 1-year high was reported on Nov, 28 by Barchart.com. If the $35.10 price target is reached, the company will be worth $24.38M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 17,716 shares traded hands. Nutraceutical Int’l Corp. (NASDAQ:NUTR) has risen 32.63% since April 25, 2016 and is uptrending. It has outperformed by 26.61% the S&P500.
Analysts await Nutraceutical Int’l Corp. (NASDAQ:NUTR) to report earnings on January, 26.
According to Zacks Investment Research, “Nutraceutical Int’l Corp. manufactures and markets quality branded nutritional supplements sold to health food stores. The company sells its branded products under the Solaray, KAL, NaturalMax, VegLife, Premier One, Solar Green, Action Labs, and Natural Sport brand names. The company also manufactures bulk materials for use in its own products and for sale to other manufacturers and marketers of nutritional supplements under the names Monarch Nutritional Laboratories and Great Basin Botanicals.”
Insitutional Activity: The institutional sentiment increased to 1.44 in Q2 2016. Its up 0.47, from 0.97 in 2016Q1. The ratio improved, as 4 funds sold all Nutraceutical Int’l Corp. shares owned while 29 reduced positions. 7 funds bought stakes while 25 increased positions. They now own 7.17 million shares or 3.50% less from 7.43 million shares in 2016Q1.
State Street, a Massachusetts-based fund reported 173,789 shares. Dalton Greiner Hartman Maher And has 0.31% invested in the company for 218,513 shares. Bancshares Of New York Mellon holds 0% or 43,903 shares in its portfolio. Wellington Gru Ltd Liability Partnership owns 231,851 shares or 0% of their US portfolio. Moreover, Renaissance Technologies Limited Liability Company has 0.02% invested in Nutraceutical Int’l Corp. (NASDAQ:NUTR) for 504,700 shares. Martingale Asset Limited Partnership, a Massachusetts-based fund reported 31,717 shares. Walleye Trading Ltd Liability Co holds 0% or 700 shares in its portfolio. The California-based Los Angeles Cap Mgmt And Equity Rech Incorporated has invested 0% in Nutraceutical Int’l Corp. (NASDAQ:NUTR). The Massachusetts-based Geode Mngmt Ltd has invested 0% in Nutraceutical Int’l Corp. (NASDAQ:NUTR). Moreover, Axa has 0% invested in Nutraceutical Int’l Corp. (NASDAQ:NUTR) for 35,650 shares. Bnp Paribas Arbitrage owns 322 shares or 0% of their US portfolio. Moreover, Blackrock Institutional Tru Na has 0% invested in Nutraceutical Int’l Corp. (NASDAQ:NUTR) for 395,274 shares. Schwab Charles Inv Mgmt Incorporated holds 0% or 21,570 shares in its portfolio. Nationwide Fund Advsrs owns 7,873 shares or 0% of their US portfolio. Dimensional Fund Advsr Lp has 0.01% invested in the company for 646,114 shares.
Another recent and important Nutraceutical Int’l Corp. (NASDAQ:NUTR) news was published by Marketwatch.com which published an article titled: “Fish Oil Market is Expected to Reach $2.63 Billion, Globally, by 2020 – Allied …” on May 27, 2015.
NUTR Company Profile
Nutraceutical International Corporation (Nutraceutical), incorporated on September 17, 1993, is a manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products through domestic health and natural food stores. The Company’s products include vitamins and minerals, herbs, specialty formulas, personal care products, homeopathics, functional foods and other products. The Firm also markets and distributes branded nutritional supplements and other natural products internationally through health and natural product distributors and retailers. The Firm offers products in various formulations and delivery forms, including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.